Japan Strategist Roundtable: Jesper Koll - What Is Different This Time?

... reform versus a sprinter pace. Koll: The most tangible benefit is in the health care segment. Take stem cell research. If you are an entrepreneur in stem cell research, you are doing it in Japan. This is not an ethics argument, but you can do ...

http://ift.tt/1yQMXok